MedMira Announces Product Update
30 déc. 2020 21h00 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, Dec. 30, 2020 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR), is pleased to announce its validated REVEALCOVID-19TM PLUS Total Antibody Test for the detection of...
MedMira Reports First Quarter Results FY2021
24 déc. 2020 19h00 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, Dec. 24, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended October 31, 2020. Profit and Loss...
MedMira Reports FY2020 Fourth Quarter and Year End Financial Results
30 nov. 2020 19h00 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, Nov. 30, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the financial year ended July 31, 2019. Profit and Loss...
MedMira reports additional independent performance evaluation results of REVEALCOVID-19™ Total Antibody Test
07 oct. 2020 09h28 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the results of the latest independent performance evaluation results of...
REVEALCOVID-19™ Total Antibody Test Sensitivity and Cross-Reactivity Analysis
03 sept. 2020 17h00 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) reports findings to further emphasize the high sensitivity of REVEALCOVID-19™ Total Antibody Test 7...
MedMira’s July Update as per the IIROC Request
10 juil. 2020 09h48 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, July 10, 2020 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) would like to issue a statement to address the request form the Investment Industry Regulatory...
MedMira Reports Third Quarter Results FY2020
29 juin 2020 20h00 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, June 29, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR), reported today on its financial results for the quarter ended April 30, 2020. Important Notice The...
MedMira gibt exklusive Vertriebspartnerschaft mit Webb Diagnostic Technologies für Gesamtantikörpertest REVEALCOVID-19™ in den USA und erste Bestellung bekannt
28 mai 2020 11h38 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, May 28, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR) gibt bekannt, dass das Unternehmen für den Vertrieb des Gesamtantikörpertests REVEALCOVID-19™ eine exklusive...
MedMira annonce un partenariat de distribution exclusive avec Webb Diagnostic Technologies et une commande initiale pour son test global de détection d'anticorps REVEALCOVID-19™ aux États-Unis
28 mai 2020 11h38 HE
|
MedMira Inc.
HALIFAX, Nouvelle-Écosse, 28 mai 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV : MIR) annonce la conclusion d'un accord de distribution exclusive avec Webb Diagnostic Technologies,...
MedMira Announces Exclusive Distribution Partnership with Webb Diagnostic Technologies and Initial Order for REVEALCOVID-19™ Total Antibody Test in the U.S.
27 mai 2020 13h00 HE
|
MedMira Inc.
HALIFAX, Nova Scotia, May 27, 2020 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV: MIR) announces that company has entered into an Exclusive Distribution Agreement with Webb Diagnostic...